Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody
Titel:
Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody
Auteur:
Liu, Binliang Xie, Ning Tian, Can Feng, Ronghua Hu, Zhe-Yu Li, Jing Liu, Liping Xiao, Huawu Yang, Xiaohong Zeng, Mengsi Wu, Hui Lu, Jun Gao, Jianxiang Hu, Xuming Cao, Min Shui, Zhengrong Tang, Yu Wu, Tao Ouyang, Quchang